COVID-19 patients with cardiovascular disease more likely to develop blood clots post-hospital discharge, Feinstein Institutes study streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Researchers reveal blood clot risk and anticoagulation benefits in discharged COVID-19 patients
Apr 9 2021
In the largest study of its kind, Feinstein Institutes for Medical Research and Northwell COVID-19 Research Consortium researchers reveal blood clot risk and anticoagulation benefits in hospitalized coronavirus disease 2019 (COVID-19) patients who have been recently discharged from the hospital. The report, recently published in the journal
Blood, finds that prophylactic anticoagulants reduce the risk of major thromboembolic events and death by 46 percent.
Alex C. Spyropoulos, MD, professor at the Feinstein Institutes speaks with a colleague. Image Credit: Feinstein Institutes
The prospective multicenter registry, named CORE-19, examined 4,906 adult patients with COVID-19 who were hospitalized at Northwell Health hospitals, New York’s largest health system, between March 1 through May 31, 2020, and was led by Alex C. Spyropoulos, MD, professor at the Feinstein Institutes